Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Computational Biology and Chemistry|May 1, 2026
Identification of naringenin chalcone as a key gut metabolite for bladder cancer intervention: An integrated strategy combining network pharmacology and molecular dynamics simulationRuize Qin, Cheng Li, Tianwei Zhang, et al.Frontiers in Public Health|June 13, 2025
Development of a data-driven urban immunity assessment model: providing a new benchmark for urban governance under public health emergenciesPeng Cui, Saiya Cao, Ruize Qin, et al.Frontiers in Public Health|November 3, 2025
Measuring and optimizing the urban community resilience against public health emergencies: a case study in Nanjing, ChinaPeng Cui, Saiya Cao, Ruize Qin, et al.Cell Death & Disease|November 18, 2024
NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathwayChangxue Liu, Huaixi Ge, Chengquan Shen, et al.Investigative and Clinical Urology|May 7, 2024
Identification and validation of a signature based on myofibroblastic cancer-associated fibroblast marker genes for predicting prognosis, immune infiltration, and therapeutic response in bladder cancerRuize Qin, Xiaocheng Ma, Shi Pu, et al.Discover Oncology|May 21, 2026
Integrating machine learning and structural analysis to decipher benzo[a]pyrene-induced bladder cancer networksXinzhao Zhao, Ruize Qin, Chengquan Shen, et al.Materials (Basel, Switzerland)|November 13, 2025
Study on Seismic Behavior of Earthquake-Damaged Joints Retrofitted with CFRP in Hybrid Reinforced Concrete-Steel FramesXiaotong Ma, Tianxiang Guo, Yuxiao Xing, et al.Plants (Basel, Switzerland)|June 26, 2026
Screening and Evaluation of Salt-Tolerant Wheat CultivarsHongping Chang, Wei Fu, Zhichao Zhang, et al.Journal for Immunotherapy of Cancer|February 3, 2026
Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancerChengquan Shen, Changxue Liu, Ding Hu, et al.Journal of Translational Medicine|February 28, 2025
The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world studyHuaixi Ge, Changxue Liu, Chengquan Shen, et al.Pageof 2